Literature DB >> 7867969

Weak antioxidant defenses make the heart a target for damage in copper-deficient rats.

Y Chen1, J T Saari, Y J Kang.   

Abstract

Copper deficiency causes more salient pathologic changes in the heart than in the liver of rats. Although oxidative stress has been implicated in copper deficiency-induced pathogenesis, little is known about the selective toxicity to the heart. Therefore, we examined the relationship between the severity of copper deficiency-induced oxidative damage and the capacity of antioxidant defense in heart and liver to investigate a possible mechanism for the selective cardiotoxicity. Weanling rats were fed a purified diet deficient in copper (0.4 microgram/g diet) or one containing adequate copper (6.0 microgram/g diet) for 4 weeks. Copper deficiency induced a 2-fold increase in lipid peroxidation in the heart (thiobarbituric assay) but did not alter peroxidation in the liver. The antioxidant enzymatic activities of superoxide dismutase, catalase, and glutathione peroxidase were, respectively, 3-, 50- and 1.5-fold lower in the heart than in the liver, although these enzymatic activities were depressed in both organs by copper deficiency. In addition, the activity of glutathione reductase was 4 times lower in the heart than in the liver. The data suggest that a weak antioxidant defense system in the heart is responsible for the relatively high degree of oxidative damage in copper-deficient hearts.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7867969     DOI: 10.1016/0891-5849(94)90092-2

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  24 in total

Review 1.  Nrf2 at the heart of oxidative stress and cardiac protection.

Authors:  Qin M Chen; Anthony J Maltagliati
Journal:  Physiol Genomics       Date:  2017-11-29       Impact factor: 3.107

Review 2.  Micronutrients and their supplementation in chronic cardiac failure. An update beyond theoretical perspectives.

Authors:  Klaus K Witte; Andrew L Clark
Journal:  Heart Fail Rev       Date:  2006-03       Impact factor: 4.214

3.  Spirulina platensis prevents high glucose-induced oxidative stress mitochondrial damage mediated apoptosis in cardiomyoblasts.

Authors:  Pratiksha Jadaun; Dhananjay Yadav; Prakash Singh Bisen
Journal:  Cytotechnology       Date:  2017-07-12       Impact factor: 2.058

4.  Iron overload and heart fibrosis in mice deficient for both beta2-microglobulin and Rag1.

Authors:  M M Santos; M de Sousa; L H Rademakers; H Clevers; J J Marx; M W Schilham
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

5.  Trientine selectively delivers copper to the heart and suppresses pressure overload-induced cardiac hypertrophy in rats.

Authors:  Jiaming Liu; Chen Chen; Yinjie Liu; Xiaorong Sun; Xueqin Ding; Liying Qiu; Pengfei Han; Y James Kang
Journal:  Exp Biol Med (Maywood)       Date:  2018-11-24

6.  Effects of MnDPDP and ICRF-187 on Doxorubicin-Induced Cardiotoxicity and Anticancer Activity.

Authors:  Tino Kurz; Derek Grant; Rolf Gg Andersson; Robertson Towart; Michelandrea De Cesare; Jan Olof G Karlsson
Journal:  Transl Oncol       Date:  2012-08-01       Impact factor: 4.243

7.  Changes in copper and zinc status and response to dietary copper deficiency in metallothionein-overexpressing transgenic mouse heart.

Authors:  Y James Kang; Youchun Jiang; Jack T Saari
Journal:  J Nutr Biochem       Date:  2007-08-17       Impact factor: 6.048

8.  Thymosin beta 4 prevents oxidative stress by targeting antioxidant and anti-apoptotic genes in cardiac fibroblasts.

Authors:  Sandeep Kumar; Sudhiranjan Gupta
Journal:  PLoS One       Date:  2011-10-25       Impact factor: 3.240

9.  Dietary copper supplementation reverses hypertrophic cardiomyopathy induced by chronic pressure overload in mice.

Authors:  Youchun Jiang; Corey Reynolds; Chang Xiao; Wenke Feng; Zhanxiang Zhou; Walter Rodriguez; Suresh C Tyagi; John W Eaton; Jack T Saari; Y James Kang
Journal:  J Exp Med       Date:  2007-03-05       Impact factor: 14.307

10.  Different effects of resveratrol on dose-related Doxorubicin-induced heart and liver toxicity.

Authors:  Jaroslaw Dudka; Renata Gieroba; Agnieszka Korga; Franciszek Burdan; Wlodzimierz Matysiak; Barbara Jodlowska-Jedrych; Slawomir Mandziuk; Elzbieta Korobowicz; Marek Murias
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-26       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.